Fluorescence-Guided Surgery for Early Stomach Cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a very early stage of stomach cancer (cT1N0M0) or have had a non-curative endoscopic resection (ESD) that did not completely remove the cancer.
- You have not had any previous stomach surgery, chemotherapy, or radiation therapy.
- You are in good general health (able to do daily activities, no major organ problems).
- You are not pregnant or breastfeeding, and you are not currently in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two surgical techniques for early-stage stomach cancer. It aims to remove the tumor and check nearby lymph nodes more precisely, which may help guide treatment and reduce side effects.
This trial tests a new image-guided method to find and remove sentinel lymph nodes (the first nodes where cancer might spread) in people with early stomach cancer. The goal is to precisely remove only the affected lymph nodes during surgery, which might mean a less extensive operation and fewer side effects.
This trial tests a new way to find and remove early stomach cancer using a fluorescent dye that makes the cancer glow during surgery. It may help doctors be more precise and preserve more of your stomach.
This trial tests a surgical technique that combines two types of minimally invasive procedures (laparoscopy and endoscopy) to find and remove the first lymph node that might contain cancer (called the sentinel lymph node) in people with early stomach cancer. The goal is to remove only the necessary lymph nodes, potentially reducing side effects while ensuring the cancer hasn't spread.
This study compares two approaches after a non-curative ESD for early stomach cancer: one that removes sentinel lymph nodes (the first nodes where cancer might spread) and one that does not. Participating may help find out if removing these nodes improves outcomes.
This trial tests whether a minimally invasive camera-guided surgical procedure (laparoscopy) can better detect hidden cancer spread in patients with advanced stomach cancer. The goal is to help doctors plan the best treatment and improve outcomes.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.